Dinoprost Tromethamine

CAS 38562-01-5 2 current recordsSmall Molecule

Who holds supplier records for Dinoprost Tromethamine? 2 organisations hold a current record for Dinoprost Tromethamine: an active US FDA Type II Drug Master File or a CEP. 2 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: United States (1) and Hungary (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Dinoprost Tromethamine: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/dinoprost-tromethamine

Reading the evidence

  • 2 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • No company-level GMP certificate matched

    No current EU or UK GMP certificate was matched to these organisations. That is not a negative finding; ask each candidate for its certificate and latest inspection outcome.

Current records (2)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Dinoprost Tromethamine. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Dinoprost Tromethamine sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (2)

Certificates of Suitability on the EDQM register for Dinoprost Tromethamine, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

HolderCountryCertificateIssuedEU GMP at holder's address
PHARMACIA & UPJOHN COMPANY LLC KalamazooUS
CEP 2016-337 - Rev 01
Dinoprost trometamol
Jan 2024—
EUROAPI HUNGARY Ltd. BudapestHU
R0-CEP 2021-310 - Rev 00
Dinoprost trometamol
Feb 2023—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Dinoprost Tromethamine is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1200896).

Chemical identity

IUPAC name
2-amino-2-(hydroxymethyl)propane-1,3-diol;(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]cyclopentyl]hept-5-enoic acid
Canonical SMILES
CCCCC[C@@H](/C=C/[C@H]1[C@@H](C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O)O.C(C(CO)(CO)N)O
InChIKey
IYGXEHDCSOYNKY-RZHHZEQLSA-N
Synonyms
Dinoprost trometamol, Dinoprost tromethamine, Lutalyse, NSC-196515, PGF2ALPHA THAM, PGF2ALPHA-THAM, PGF2A THAM, Prostaglandin f 2 alpha, Prostaglandin f2.alpha. tromethamine salt, Prostin f2 alpha, U-14,583E, U-14-583E

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Dinoprost Tromethamine?

2 organisations hold an active US FDA Type II Drug Master File or a CEP for Dinoprost Tromethamine: Pharmacia & Upjohn, Inc. (United States) and EUROAPI HUNGARY LTD (Hungary). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Dinoprost Tromethamine Drug Master Files are active?

Pharmacia & Upjohn, Inc. (DMF 5319). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

Does Dinoprost Tromethamine have a European Certificate of Suitability?

Yes. 2 organisations hold a valid CEP for Dinoprost Tromethamine on the EDQM register, including PHARMACIA & UPJOHN COMPANY LLC Kalamazoo (US) and EUROAPI HUNGARY Ltd. Budapest (HU). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Dinoprost Tromethamine supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Dinoprost Tromethamine?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.